We analyzed the correlation of FN1, ITGA4, ITGA5, ITGAV, ITGB1, ITGB3 and ITGB6 with disease status, risk of tumor recurrence according to the 2015 American Thyroid Association guidelines (Haugen et al. 2015), and patient outcome. This evidence concerns the gene ITGAV and neoplasm.